Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1190/week)
    • Manufacturing(600/week)
    • Technology(1141/week)
    • Energy(399/week)
    • aviation(130/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

BRAF

Jun 22, 2020
ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA
Oct 08, 2019
IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors outside of Uveal Melanoma and a Collaboration with Foundation Medicine in support of its Tumor-Agnostic GNAQ/11 Basket Trial
Jul 11, 2019
Novartis Offers Free Genetic Mutation Testing Program for Advanced Melanoma Patients; Results Can Help Doctors and Patients Making Cancer Treatment Decisions
Jul 11, 2019
IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11 Mutations
Jul 10, 2019
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Jun 18, 2019
The BRAF kinase inhibitors market will register a CAGR of over 8% by 2023
Jun 17, 2019
Pfizer to Acquire Array BioPharma
May 29, 2019
Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference
May 16, 2019
Blood Test Can Measure Effectiveness of Treatments for Aggressive Skin Cancers
Jan 03, 2019
REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019
Nov 28, 2018
Sentinel Biomedical launches new non-invasive laboratory analysis
Aug 14, 2018
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
Apr 30, 2018
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Apr 20, 2018
Global Melanoma Market Report 2018 - Anticipated to Reach a Market Value of $14 Billion by 2024
Jan 20, 2018
Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial
Dec 22, 2017
Novartis' combination therapy Tafinlar® + Mekinist® granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma
Nov 06, 2017
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer
Oct 30, 2017
Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim's BI 882370, a Novel and Potent RAF Inhibitor against Solid Tumors
Sep 10, 2017
Novartis Phase III study demonstrates adjuvant Tafinlar® + Mekinist® reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma
Sep 08, 2017
Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress
  •  
  • Page 1
  • ››

Latest News

Jun 14, 2025

Gold Road Inc. Acquires Arizona Gold Mine, Upsizes Financing to C$3M, Welcomes Former Central Bank Governor...

Jun 14, 2025

President Trump Approves Historic Partnership between U. S. Steel and Nippon Steel

Jun 14, 2025

Federal Court in Delaware Dismisses Antitrust Challenge to Wabtec-GE Transportation Merger

Jun 14, 2025

EY US announces Gabriel Rio of Milestone Environmental Services as an Entrepreneur Of The Year® 2025 Gulf...

Jun 14, 2025

India plane crash orphans sisters after father's trip to scatter wife's ashes

Jun 14, 2025

Ram Brand Launches 'Never Stop Being American' Marketing Campaign, New Brand Ethos 'Nothing...

Jun 14, 2025

Klein Funding and Bybit Partner to Launch a New Era of Crypto Prop Trading

Jun 14, 2025

Xinhua Silk Road: 3rd Tianjin International Shipping Industry Expo kicks off to boost win-win cooperation

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia